Ardsley Advisory Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$30.7M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$15.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.4M |
| 4 |
Microsoft
MSFT
|
+$15.2M |
| 5 |
SMAR
Smartsheet Inc.
SMAR
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STKL
SunOpta
STKL
|
+$19.9M |
| 2 |
T-Mobile US
TMUS
|
+$14.5M |
| 3 |
EVA
Enviva Inc.
EVA
|
+$11.3M |
| 4 |
FTAI Aviation
FTAI
|
+$10.4M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$8.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.02% |
| 2 | Healthcare | 12.33% |
| 3 | Communication Services | 6.21% |
| 4 | Utilities | 5.54% |
| 5 | Industrials | 4.16% |
Similar funds
Ardsley Advisory Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Ardsley Advisory Partners held 184 positions worth $822M, up 35% from $609M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Ardsley Advisory Partners deployed $159M of net new capital in Q1 2021, opening 56 new positions and adding to 30 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 70,000 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was SunOpta, an estimated $19.9M trimmed.
- Ardsley Advisory Partners's largest Q1 2021 buy was Vertex Pharmaceuticals: 70,000 shares worth $15M.
- Ardsley Advisory Partners added most to Baidu in Q1 2021, an estimated $30.7M increase.
- Ardsley Advisory Partners's biggest Q1 2021 reduction was SunOpta, cutting an estimated $19.9M.
- Ardsley Advisory Partners fully exited Enviva Inc. in Q1 2021, selling an estimated $11.3M.
- Ardsley Advisory Partners's ten largest holdings make up 48% of its $822M portfolio in Q1 2021.
- Ardsley Advisory Partners opened 56 new positions and closed 61 in Q1 2021.
- Ardsley Advisory Partners's portfolio value rose 35% quarter-over-quarter to $822M.
Based on Ardsley Advisory Partners's 13F filing for Q1 2021, filed 17 May 2021.